Visitor records obtained Wednesday by The Associated Press show that top aides to President Barack Obama have met often with lobbyists and Democratic political strategists.
President Barack Obama's top aides met frequently with lobbyists and health care industry heavyweights as his administration pieced together a national health care overhaul, according to White House visitor records obtained by The Associated Press.
Friday, 20 Nov 2009 | Source: The Associated Press
The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday.
It's not just spending on U.S. healthcare that is breaking records. Drugmakers, insurers and industry groups are on track to spend an all-time high of more than $500 million this year to influence Congress' revamp of the healthcare system.
Friday, 20 Nov 2009 | Source: The Associated Press
Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.
Thursday, 19 Nov 2009 | Source: The Associated Press
Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent.
Evidence is mounting that morphine, commonly used to manage pain, may accelerate cancer growth, but a newly-approved drug that blocks its side effects could also keep tumors from spreading, U.S. researchers said on Wednesday.
Evidence is mounting that morphine, commonly used to manage pain, may accelerate cancer growth, but a newly-approved drug that blocks its side effects could also keep tumors from spreading, U.S. researchers said on Wednesday.
Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system.
Wednesday, 18 Nov 2009 | Source: The Associated Press
Shares of Vivus Inc. gained ground Wednesday after the company said its erectile dysfunction drug candidate avanafil reached its key goal in a late-stage clinical study.
Wednesday, 18 Nov 2009 | Source: The Associated Press
Scientists from a not-for-profit foundation will test 150,000 Pfizer Inc. drug candidates as part of a search for treatments for three tropical diseases that are spread by insects.
High doses of an experimental heart medicine being developed by Merck & Co MRK.N continued to show beneficial effects on both good HDL and bad LDL cholesterol levels eight weeks after patients stopped taking the drug, in a mid-stage study.
Wednesday, 18 Nov 2009 | Source: The Associated Press
Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals.
With the health care debate continuing, how can investors make money in the sector? Barbara Ryan, managing director and senior pharmaceuticals analyst at Deutsche Bank Securities, and Charles Boorady, health care providers analyst at Citigroup, shared their insights.... Read More